Mr Kevin Ross
- Data Engineer (Planning, Insight & Analytics)
email:
Kevin.Ross@glasgow.ac.uk
Planning, Insight and Analytics, Pearce Lodge, Gilmorehill Campus, Glasgow, G12 8QQ
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Kevin.Ross@glasgow.ac.uk
Planning, Insight and Analytics, Pearce Lodge, Gilmorehill Campus, Glasgow, G12 8QQ
Askarieh, A., Morrison, I., Ross, K., McCowan, C. , Matthews, K., Kidd, B. and Heath, C. A. (2021) Medication adherence, utilization of healthcare services, and mortality of patients with epilepsy on opiate replacement therapy: a retrospective cohort study. Epilepsy and Behavior, 117, 107829. (doi: 10.1016/j.yebeh.2021.107829) (PMID:33621811)
Packard, C. J. , Young, R. , Ross, K., Ford, I. , Ambegaonkar, B. M., Brudi, P. and McCowan, C. (2017) Modelling total coronary heart disease burden and long-term benefit of cholesterol lowering in middle aged men with and without a history of cardiovascular disease. European Heart Journal: Quality of Care and Clinical Outcomes, 3(4), pp. 281-288. (doi: 10.1093/ehjqcco/qcx012) (PMID:29044395)
Askarieh, A., Morrison, I., Ross, K., McCowan, C. , Matthews, K., Kidd, B. and Heath, C. A. (2021) Medication adherence, utilization of healthcare services, and mortality of patients with epilepsy on opiate replacement therapy: a retrospective cohort study. Epilepsy and Behavior, 117, 107829. (doi: 10.1016/j.yebeh.2021.107829) (PMID:33621811)
Packard, C. J. , Young, R. , Ross, K., Ford, I. , Ambegaonkar, B. M., Brudi, P. and McCowan, C. (2017) Modelling total coronary heart disease burden and long-term benefit of cholesterol lowering in middle aged men with and without a history of cardiovascular disease. European Heart Journal: Quality of Care and Clinical Outcomes, 3(4), pp. 281-288. (doi: 10.1093/ehjqcco/qcx012) (PMID:29044395)